These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21950543)
41. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study. Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072 [TBL] [Abstract][Full Text] [Related]
42. Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease. Gennaro R; Barletta D; Paulis G Int Urol Nephrol; 2015 Oct; 47(10):1595-602. PubMed ID: 26257044 [TBL] [Abstract][Full Text] [Related]
43. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231 [TBL] [Abstract][Full Text] [Related]
44. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study. Moncada I; Krishnappa P; Romero J; Torremade J; Fraile A; Martinez-Salamanca JI; Porst H; Levine L BJU Int; 2019 Apr; 123(4):694-702. PubMed ID: 30365247 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease. Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974 [TBL] [Abstract][Full Text] [Related]
46. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease. Cavallini G; Modenini F; Vitali G Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941 [TBL] [Abstract][Full Text] [Related]
47. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study. Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of Collagenase Clostridium histolyticum (Xiapex Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279 [TBL] [Abstract][Full Text] [Related]
49. Peyronie's disease: clinical treatment. Aita G; Ros CTD; Silvinato A; Bernardo WM Rev Assoc Med Bras (1992); 2019; 65(10):1231-1239. PubMed ID: 31721953 [No Abstract] [Full Text] [Related]
50. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. Safarinejad MR Int J Impot Res; 2004 Jun; 16(3):238-43. PubMed ID: 14973528 [TBL] [Abstract][Full Text] [Related]
51. Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial. Soh J; Kawauchi A; Kanemitsu N; Naya Y; Ochiai A; Naitoh Y; Fujiwara T; Kamoi K; Miki T J Sex Med; 2010 Nov; 7(11):3743-9. PubMed ID: 20584114 [TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study. Paulis G; Barletta D; Turchi P; Vitarelli A; Dachille G; Fabiani A; Gennaro R Res Rep Urol; 2016; 8():1-10. PubMed ID: 26770906 [TBL] [Abstract][Full Text] [Related]
53. Intralesional verapamil injection for the treatment of Peyronie's disease. Levine LA; Merrick PF; Lee RC J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561 [TBL] [Abstract][Full Text] [Related]
54. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report. Gallo L; Sarnacchiaro P Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797 [TBL] [Abstract][Full Text] [Related]
55. Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study. Gontero P; Di Marco M; Giubilei G; Bartoletti R; Pappagallo G; Tizzani A; Mondaini N J Sex Med; 2009 Feb; 6(2):558-66. PubMed ID: 19138361 [TBL] [Abstract][Full Text] [Related]
56. Update on medical management of Peyronie's disease. Tan RB; Sangkum P; Mitchell GC; Hellstrom WJ Curr Urol Rep; 2014 Jun; 15(6):415. PubMed ID: 24740275 [TBL] [Abstract][Full Text] [Related]
57. The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease. Tuygun C; Ozok UH; Gucuk A; Bozkurt IH; Imamoglu MA Int Urol Nephrol; 2009; 41(1):113-8. PubMed ID: 18592390 [TBL] [Abstract][Full Text] [Related]
58. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location. Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333 [TBL] [Abstract][Full Text] [Related]
59. Surgical Reconstruction of Penile Curvature due to Peyronie's Disease by Plaque Incision and Buccal Mucosa Graft. Ainayev Y; Zhanbyrbekuly U; Gaipov A; Suleiman M; Kadyrzhanuly K; Kissamedenov N; Zhaparov U; Akhmetov D; Khairli G J Sex Med; 2021 Jul; 18(7):1308-1316. PubMed ID: 34148821 [TBL] [Abstract][Full Text] [Related]
60. Intralesional verapamil for the treatment of Peyronie's disease: a review. Levine LA; Estrada CR Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]